Browsing
     by title


0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

or enter first few letters:   
OK
Peer Reviewed
See detailInheritance and wealth composition
Pestieau, Pierre ULg; Perelman, Sergio ULg

in Journal of Population Economics (1992), (5), 305-318

This paper studies the effects of variables pertaining to alternative bequest motives on the composition of households' portofolio. It relies on a 1986 survey on the assets structure of 5600 French ... [more ▼]

This paper studies the effects of variables pertaining to alternative bequest motives on the composition of households' portofolio. It relies on a 1986 survey on the assets structure of 5600 French households. The main conclusion is that bequest motives indeed influence the composition of households' wealth. However, available data does not allow one to sort out the influence of specific models of inheritance. [less ▲]

Detailed reference viewed: 13 (2 ULg)
Full Text
Peer Reviewed
See detailInheritance of sex in two ZZ pseudofemale lines of tilapia Oreochromis aureus
Desprez, D.; Mélard, Charles ULg; Hoareau, M. C. et al

in Aquaculture (2003), 218(1-4), 131-140

This paper reports a study on the sex determination system of the blue tilapia, Oreochromis aureus. Investigations were carried out using a pseudofemale line in two populations of O. aureus, known as ... [more ▼]

This paper reports a study on the sex determination system of the blue tilapia, Oreochromis aureus. Investigations were carried out using a pseudofemale line in two populations of O. aureus, known as Egyptian Population (EP) and Israel Population (IP). In O. aureus, males are the homogametic sex (ZZ/ZW), and sex reversal of fry with estradiol results in the production of some functional sex-reversed fish with a female phenotype and ZZ male genotype, known as pseudofemales or A-females. Crosses between ZZ pseudofemales and ZZ males theoretically should provide monosex ZZ male progeny only. We have studied the sex ratios of progeny from 43 IP (F-2 to F-3 generations) and 51 EP (F-1 to F-5 generations), pair-matings between normal males and pseudofemales. In IP, the male percentage in progenies ranged between 83% to 100% in F-2 and 66% to 100% in F-3. In EP, male percentage was more constant, varying from 88% to 100% in F-1, from 96% to 100% in F-3 and from 97% to 100% in F-5. In EP, F-2 and F-4 pseudofemales produced only monosex male progeny. This apparent difference in sex ratio frequency distributions between the two O. aureus pseudofemale lines could be due to the selection of males. EP pseudofemales were mated with their siblings for F-2 and F-3 pseudofemales or with closely related males for F-4 and F-5 pseudofemales. Conversely, IP pseudofemales were crossed with nonrelated males originating from research center broodstock, resulting in a higher proportion of females in sex ratio of progenies from successive generations of pseudofemales. The role of inbreeding is discussed in the context of predominantly monofactorial sex chromosome determination system operating in this species, influenced by other factors (genetic and environmental). The present study also shows that it is possible to fix the male sex determining factors (Z sex chromosome and genetic factors) in a line of pseudofemales, producing a high percentage of male progeny in five successive generations. (C) 2003 Elsevier Science B.V. All rights reserved. [less ▲]

Detailed reference viewed: 143 (1 ULg)
Full Text
See detailInherited defects in Belgian blue cattle
Sartelet, Arnaud ULg

Scientific conference (2009, December 11)

Detailed reference viewed: 82 (16 ULg)
Full Text
Peer Reviewed
See detailInherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study
Cleynen, Isabelle; Boucher, Gabrielle; Jostins, Luke et al

in Lancet (2016)

Detailed reference viewed: 701 (15 ULg)
Full Text
Peer Reviewed
See detailInhiber HDAC5 : un outil pour couper court à l’immortalité des cellules cancéreuses
Polese, Catherine; Mottet, Denis ULg

in Medecine Sciences : M/S (2014), 30(numero 8-9), 730-732

Detailed reference viewed: 17 (3 ULg)
Peer Reviewed
See detailLes inhibiteurs de l'enzyme de conversion dans l'infarctus du myocarde: qui, quand, comment?
Pierard, Luc ULg

in Revue Médicale de Liège (1996), 51(5), 336-40

Detailed reference viewed: 3 (0 ULg)
Full Text
Peer Reviewed
See detailLes inhibiteurs de l'enzyme de conversion dans le traitement de l'hypertension artérielle
Rorive, Georges ULg; Krzesinski, Jean-Marie ULg; Carlier, P. G.

in Revue Médicale de Liège (1988), 43(9), 321-326

Les inhibiteurs de l'enzyme de conversion nous donnent pour la première fois la possibilité d'inhiber l'activité du système rénine-angiotensine chez les patients hypertendus. Ces vasodilatateurs n ... [more ▼]

Les inhibiteurs de l'enzyme de conversion nous donnent pour la première fois la possibilité d'inhiber l'activité du système rénine-angiotensine chez les patients hypertendus. Ces vasodilatateurs n'entraînent ni tachycardie réflexe, ni rétention hydrosodée. Leur utilisation ne s'accompagne pas de modifications métaboliques mais certains effets secondaires (toux, altération de la fonction rénale), liés d'ailleurs au mode d'action, ont été relevés. Bien tolérés, ces dérivés peuvent être utilisés en monothérapie dans le traitement de l'hypertension légère, mais leur supériorité par rapport aux diurétiques et aux bêtabloquants dans la prévention des complications cardiovasculaires de l'hypertension reste à établir. [less ▲]

Detailed reference viewed: 18 (1 ULg)
Full Text
Peer Reviewed
See detailInhibiteurs de l'enzyme de conversion de l'angiotensine ou antagonistes des récepteurs de l'angiotensine 2 en pathologie cardio-vasculaire et néphrologique : que nous dit l'Evidence Based Medicine?
Krzesinski, Jean-Marie ULg; Montrieux, Christian ULg; Scheen, André ULg

in Revue Médicale de Liège (2006), 61(5-6), 414-422

Inhibitors of the renin-angiotensin system have proved their great value in secondary prevention trials for cardiovascular or renal complications. In favour of the preferred use of angiotensin receptor ... [more ▼]

Inhibitors of the renin-angiotensin system have proved their great value in secondary prevention trials for cardiovascular or renal complications. In favour of the preferred use of angiotensin receptor antagonists stand their excellent tolerance and the possible therapeutic escape seen with angiotensin converting enzyme inhibitors. For the preferential use of the latter, the arguments are the absence of a real proof of any superiority of the angiotensin receptor blockers and their higher cost. The wisdom is to initially use angiotensin converting enzyme inhibitors in secondary prevention excepted when they are not well tolerated. The large ONTARGET cardiovascular prevention trial should help solve this controversy. [less ▲]

Detailed reference viewed: 374 (4 ULg)
Full Text
Peer Reviewed
See detailLes inhibiteurs de l'enzyme de conversion: la molécule a-t-elle de l'importance?
Rorive, Georges ULg; Krzesinski, Jean-Marie ULg

in Médecine et Hygiène (1991), 49

De nombreuses, peut-être de trop nombreuses molécules, dotées d'un pouvoir d'inhibition de l'enzyme de conversion ont été introduites ces dix dernières années pour le traitement de l'hypertension ... [more ▼]

De nombreuses, peut-être de trop nombreuses molécules, dotées d'un pouvoir d'inhibition de l'enzyme de conversion ont été introduites ces dix dernières années pour le traitement de l'hypertension artérielle et de l'asystolie. Les différences entre ces molécules sont peu importantes et sont fonction de leur structure moléculaire. Le captopril, seul dérivé doté d'un groupe sulfhydrile, a un effet rapide et de durée assez brève; son utilisation s'accompagne par ailleurs de certains effets secondaires propres au groupe SR. Par contre, le délai d'action des dérivés dont le ligand est un groupe carboxyle est généralement plus tardif, leur durée d'action plus longue, justifiant une prise par jour. Il reste difficile d'affirmer que le groupe SR confère des propriétés cardioprotectrices plus importantes que celles dont jouissent les autres molécules de cette classe thérapeutique. De la même manière, à ce stade, les différences démontrées concernant la diffusion tissulaire des inhibiteurs de l'enzyme de conversion n'ont pas pu être illustrées par des observations cliniques. [less ▲]

Detailed reference viewed: 13 (0 ULg)
Full Text
See detailLes inhibiteurs de l'enzyme de conversion: leur place dans le traitement de l'hypertension artérielle
Rorive, Georges ULg; Krzesinski, Jean-Marie ULg; Carlier, P. G.

in Traité de Médecine Générale (1987)

Detailed reference viewed: 10 (0 ULg)
Full Text
Peer Reviewed
See detailInhibiteurs de la monoamine oxydase et anesthésie
Blom-Peters, L.; Larbuisson, Robert ULg; Lamy, Maurice ULg

in Revue Médicale de Liège (1988), XLIII(2), 51-56

Detailed reference viewed: 27 (2 ULg)
Full Text
See detailLes inhibiteurs de la PSCK9: une innovation majeure dans le traitement des dyslipidémies ?
PAQUOT, Nicolas ULg

in ABD- le supplément du médecin (2014), 57(6), 6-7

Detailed reference viewed: 35 (3 ULg)
Full Text
Peer Reviewed
See detailInhibiteurs du cotransporteur du glucose SGLT rénal pour traiter le diabète de type 2
SCHEEN, André ULg; RADERMECKER, Régis ULg; ERNEST, Philippe ULg et al

in Revue Médicale Suisse (2011), 7(306), 1621-1629

Detailed reference viewed: 43 (11 ULg)
Full Text
See detailLes inhibiteurs du cotransporteur du glucose SGLT rénal: une nouvelle classe thérapeutique dans le diabète de type 2
Sepulchre, Edith; RADERMECKER, Régis ULg

in Journal de Cardiologie [= JDC] = Tijdschrift voor Cardiologie [= TVC] (2013), 25(8), 429-434

Detailed reference viewed: 105 (2 ULg)
Full Text
Peer Reviewed
See detailInhibiteurs du cotransporteur du glucose SGLT2 renal pour traiter le diabete de type 2.
SCHEEN, André ULg; Radermecker, Régis ULg; Ernest, P. et al

in Revue medicale suisse (2011), 7(306), 1621-41626-9

Kidney plays a role in glucose homeostasis, not only by its capacity to produce glucose through local gluconeogenesis, but also, and even more important in presence of diabetes, by its capacity to excrete ... [more ▼]

Kidney plays a role in glucose homeostasis, not only by its capacity to produce glucose through local gluconeogenesis, but also, and even more important in presence of diabetes, by its capacity to excrete glucose in urine when hyperglycaemia exceeds tubular reabsorption threshold. Such reabsorption depends on sodium-glucose cotransporters-2 (SGLT2), which can be blocked by selective inhibitors. These pharmacological agents augment glucosuria and reduce hyperglycaemia independently of insulin. Some have already proven their efficacy to improve glucose control, in monotherapy or in combination, while promoting weight loss and without inducing hypoglycaemia. Dapagliflozin should be the first medication of this new pharmacological class to be commercialized for the management of type 2 diabetes. [less ▲]

Detailed reference viewed: 16 (2 ULg)
Peer Reviewed
See detailInhibiteurs potentiels de proteases à sérine apparentés aux antibiotiques β-lactamiques
Pirotte, Bernard ULg; Vilain, A.-C.; Vergely, I. et al

in Regard sur la Biochimie (1991), 6, 91

Detailed reference viewed: 13 (0 ULg)